ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo therapy aims to improve leukemia treatment and reduce hospital stays
Disease control Recruiting nowThis study is for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It tests a treatment plan that combines targeted drugs, reduced-intensity chemotherapy, and CAR-T cell therapy to deepen remission and reduce side effects. The g…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 07:13 UTC
-
New hope for cancer patients with kidney disease: safer CAR t therapy under study
Disease control Recruiting nowThis study looks at whether CAR T cell therapy, a type of cancer treatment that uses a patient's own immune cells, can be safely given to people with moderate to severe kidney problems. About 20 adults with certain blood cancers (like lymphoma, myeloma, or leukemia) will receive …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New combo therapy aims to boost remission in adult leukemia patients
Disease control Recruiting nowThis study tests whether adding CAR-T cell therapy after standard chemotherapy can help adults newly diagnosed with a type of leukemia (Ph-negative B-ALL) achieve deeper remission and live longer. About 77 participants will receive the combination treatment. The goal is to reduce…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:01 UTC